Rx Item-Jardiance 10Mg Empagliflozin Tab 90 By Boehringer Ingelheim

Clinical Information
Gen. Code and Des.
72488 empagliflozin ORAL TABLET 10 MG
GCN and Des.
36716 empagliflozin ORAL TABLET 10 MG
Strength
10MG
Dose Form
TABLET
Product Category
RX Pharmaceuticals
Fine Line Class
850085008510 All Rx Products
DEA Class
NC
OMP Family

AHFS Class
68201800 SODIUM-GLUC COTRANSPORT 2 (SGLT2) INHIB
Active Ingredients
15572 empagliflozin 864070440
Inactive Ingredients
2432 lactose 64044515






JARDIANCE- empagliflozin tablet, film coated
Boehringer Ingelheim Pharmaceuticals, Inc.

Empagliflozin structureFigure 5Figure 6jardiance-0152-cartonjardiance-0152-labeljardiance-0153-carton.jpgjardiance-0153-labeljardiance-0152-sample-cartonjardiance-0153-sample-carton
1??INDICATIONS AND USAGE

JARDIANCE is indicated:

as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,
? to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease.


Limitations of Use
JARDIANCE is not recommended for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.

2??DOSAGE AND ADMINISTRATION

2.1 Recommended Dosage
The recommended dose of JARDIANCE is 10 mg once daily in the morning, taken with or without food. In patients tolerating JARDIANCE, the dose may be increased to 25 mg [see Clinical Studies (14)].

In patients with volume depletion, correcting this condition prior to initiation of JARDIANCE is recommended [see Warnings and Precautions (5.1), Use in Specific Populations (8.5), and Patient Counseling Information (17)].

2.2 Patients with Renal Impairment
Assessment of renal function is recommended prior to initiation of JARDIANCE and periodically thereafter.

JARDIANCE should not be initiated in patients with an eGFR less than 45 mL/min/1.73 m2.

No dose adjustment is needed in patients with an eGFR greater than or equal to 45 mL/min/1.73 m2.

JARDIANCE should be discontinued if eGFR is less than 45 mL/min/1.73 m2 [see Warnings and Precautions (5.1, 5.3), and Use in Specific Populations (8.6)].

3??DOSAGE FORMS AND STRENGTHS

JARDIANCE tablets available as:

10 mg pale yellow, round, biconvex and bevel-edged, film-coated tablets debossed with "S 10" on one side and the Boehringer Ingelheim company symbol on the other side.
25 mg pale yellow, oval, biconvex, film-coated tablets debossed with "S 25" on one side and the Boehringer Ingelheim company symbol on the other side.

Jardiance 10Mg Tab 90 By Boehringer Inge
BRAND: JARDIANCE NDC: 00597-0152-90,597015290 UPC: 3-05970-15290-3,305970152903 Boehringer Ingelheim Jardiance 10mg Tab 90 by Boehringer Ingelheim

RX ITEM-Jardiance 10Mg Tab 90 By Boehrin
NDC 00597-0152-90 UPC/GTIN No.3-05970-15290-3 Mfg.Part No.15290 S 10, logo tablet , film-coated , yellow , round round DebossedBiconvexBeveled edge

EMPAGLIFLOZIN ORAL TABLET
Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop

Buy More Save More!
Want to do Research on this Med or need a large quantity? Email Details with quantity required to:[email protected]

AmericanPharmaWholesale.com
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.